Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Novo Nordisk’s Surprise $2.1B Rare-Disease Acquisition Deal: What You Need to Know

Deal Details: Novo Licenses Omeros’s MASP-3 Inhibitor On Oct. 15, Novo Nordisk and Seattle-based Omeros announced a definitive asset purchase and license agreement. Under the terms, Novo gains exclusive global rights to zaltenibart (OMS906) for all indications. Omeros will receive $340
Rare Earths Showdown: China’s ‘Bazooka’ Roils Markets, Trump Vows Tariffs

Rare Earths Showdown: China’s ‘Bazooka’ Roils Markets, Trump Vows Tariffs

Sources: Recent news reports and analyses (Washington Post, Reuters, AP, CNBC/FT reports, Fortune) plus industry data and tech media washingtonpost.com business-standard.com mexc.com economictimes.indiatimes.com reuters.com investopedia.com reuters.com, among others. Expert quotes and stock data are from these sources.
15 October 2025
Uber Stock Poised to Soar? Guggenheim’s $140 Price Target Explained

Uber Stock Poised to Soar? Guggenheim’s $140 Price Target Explained

Guggenheim’s Bullish Outlook On Oct. 15, Guggenheim’s Taylor Manley initiated coverage of Uber (NYSE: UBER) with a Buy and a $140 price target investing.com tipranks.com. Manley praised Uber’s “industry-leading network, technology, and brand equity,” noting that Uber’s global multi-platform network
1 130 131 132 133 134 232
Go toTop